Reducing the Risk of ADHD
Learn valuable insights into reducing the risk of attention-deficit/hyperactivity disorder (ADHD) with a combination of behavioral interventions (PTBM) and FDA-approved medications.
About this course
Attention-deficit/hyperactivity disorder (ADHD) is a chronic neurodevelopmental disorder that has been diagnosed in up to 10% of school-age children in the US and frequently persists into adulthood. A study in a large Danish cohort found that ADHD was associated with higher mortality rates in children, adolescents, and adults, mainly due to accidents. Pharmacologic treatment of ADHD in children has been reported to decrease the risk of substance abuse in adolescents, and use of ADHD medications in adults has been associated with a reduced risk of serious traffic accidents and criminal behavior. This activity discusses how to reduce the risk of ADHD with PTBM and drugs approved by the FDA for treatment of ADHD.
Course Accreditation
This course is approved for the following professions. You can get more details on each profession by clicking on it.
Instructors
John Francis Villa, MD, FACEP, FAAFP is an Emergency Medicine Specialist in Florida with more than 25 years in emergency medicine and family medicine.
You might also be interested in
Controlled Substances and Substance Abuse: Best Practices for the Healthcare Professional
2 hours$29.00Fulfils state requirementsincluded in AchieveCE+The Growing Prevalence of Breast Cancer among Adolescents, Young Adults, and People of Color
1 hour$11.00Fulfils state requirementsincluded in AchieveCE+What are others saying?
Take a look at what other healthcare professionals are saying about AchieveCE’s continuing education courses.
Get total access with AchieveCE
Get unlimited CE for one low annual fee. Save time and money by becoming a member.